Order Article Reprints
Journal: Cancers, 2022
Volume: 14
Number: 864
Article:
Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare
Authors:
by
Nicola J. Nasser, Kai Sun, Karen M. Scanlon, Mark V. Mishra and Jason K. Molitoris
Link:
https://www.mdpi.com/2072-6694/14/4/864
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.